Abstract:BACKGROUND:Berberine (BBR) is the most abundant and major active constituent of Rhizoma Coptidis (RC), which has been widely used to treat inflammatory diseases in traditional oriental medicine. Despite BBR has been found to exhibit pronounced anti-inflammatory effect, the anti-inflammatory activities of its natural derivatives were sparsely dissected out.PURPOSE:To comparatively investigate the anti-inflammatory potential of BBR, and its natural oxoderivative (oxyberberine, OBB) and reduced derivative (dihydroberberine, DHBB) in vitro and in vivo, and delineate the possible underlying mechanism.METHODS:LC-MS/MS was used to identify the natural derivatives of BBR in RC. The potential anti-inflammatory properties of BBR and its natural derivatives were comparatively evaluated in vitro by lipopolysaccharide (LPS)-induced RAW264.7 macrophages cells, and in vivo via three typical acute inflammation murine models. Some important inflammation-related molecules were analyzed by ELISA, qRT-PCR and Western blotting.RESULTS:LC-MS/MS led to the identification of BBR, OBB and DHBB in RC ethyl acetate extract. The in vitro assay indicated that BBR, OBB and DHBB (1.25, 2.5 and 5 μM) pretreatment significantly decreased the levels of pro-inflammatory cytokines tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), prostaglandinE2 (PGE2) and nitricoxide (NO), and inhibited the mRNA expressions of cyclooxygenase-2 (COX-2) and inducible nitricoxide synthase (iNOS) in a dose-dependent manner, with relative efficiency of OBB > BBR > DHBB. Furthermore, OBB, BBR and DHBB remarkably inhibited the phosphorylation of nuclear factor-κB (NF-κB) p65 and inhibitory kappa Bα (IκBα). In vivo, BBR (20 mg/kg) and OBB (5, 10, and 20 mg/kg) pretreatment significantly ameliorated the xylene-induced ear edema, carrageenan-stimulated paw edema, and acetic acid-elicited vascular permeability in mice in a dose-dependent manner, with OBB exhibiting superior anti-inflammatory effect at the same dose (20 mg/kg). Histopathological analysis indicated that OBB and BBR could markedly attenuate the inflammatory deterioration and decrease the cellular infiltration in paw tissues. Additionally, the carrageenan-induced increases in TNF-α, IL-6, IL-1β, PGE2 and NO productions, and COX-2 and iNOS mRNA expressions were effectually and concentration-dependently suppressed by OBB and BBR pretreatment.CONCLUSION:The anti-inflammatory activity of BBR and its natural derivatives was in the order of OBB > BBR > DHBB. OBB was for the first time found to be endowed with pronounced anti-inflammatory property, which was probably associated with suppressing the activation of NF-κB signaling pathway, and the subsequent gene expressions and productions of pro-inflammatory mediators. The results might contribute to illuminating the pharmacodynamic underpinnings of RC and provide evidence for developing OBB as a safe and promising natural lead compound in inflammation treatment.

Glucocorticoid Receptor-Mediated Alleviation of Inflammation by Berberine: in Vitro, in Silico and in Vivo Investigations.

Highly Bioavailable Berberine Formulation Improves Glucocorticoid Receptor-mediated Insulin Resistance Via Reduction in Association of the Glucocorticoid Receptor with Phosphatidylinositol-3-kinase.

Berberine ameliorates inflammation by inhibiting MrgprB2 receptor-mediated activation of mast cell in mice

The anti-inflammatory potential of berberine in vitro and in vivo

Comparison of Anti-Inflammatory Effects of Berberine, and Its Natural Oxidative and Reduced Derivatives from Rhizoma Coptidis in Vitro and in Vivo

Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis

Berberine alleviates ulcerative colitis by inhibiting inflammation through targeting IRGM1

Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology

Anti‐inflammatory mechanism of berberine on lipopolysaccharide‐induced IEC‐18 models based on comparative transcriptomics

GR-mediated Anti-Inflammation of Α-Boswellic Acid: Insights from in Vitro and in Silico Studies.

Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation

Withaferin A: A Potential Selective Glucocorticoid Receptor Modulator with Anti-Inflammatory Effect

Protopanaxadiol Derivative: A Plant Origin of Novel Selective Glucocorticoid Receptor Modulator with Anti-inflammatory Effect

Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy

Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway

Macrophage-Targeted Berberine-Loaded Β-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis

Berberine Ameliorates Collagen-Induced Arthritis in Rats by Suppressing Th17 Cell Responses Via Inducing Cortistatin in the Gut.

Inhibitory Effects of Berberine on Proinflammatory M1 Macrophage Polarization Through Interfering with the Interaction Between TLR4 and MyD88.

Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways.

Effect of Berberine on Lipopolysaccharide-Induced Monocyte Chemotactic Protein-1 and Interleukin-8 Expression in a Human Retinal Pigment Epithelial Cell Line

In Vitro Anti-Inflammatory Potency of Sanguinarine and Chelerythrine Via Interaction with Glucocorticoid Receptor